Anjo.ai
Provides early detection and monitoring of anaphylaxis in children through AI-integrated wearable devices.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Grant | |
| Total Funding | 000k | ||
Related Content
Anjo.ai is a pioneering startup focused on revolutionizing the management of life-threatening allergies in children. The company operates in the health technology market, specifically targeting parents and healthcare providers who deal with severe allergic reactions. Anjo.ai's core offering is an advanced allergic reactions event log that can be reviewed by allergists. This log can be manually updated to provide comprehensive tracking for both personal and professional use.
The heart of Anjo.ai's solution lies in its AI-driven model, which leverages large-scale data analysis and personalization to learn about a child's health and behavior. This model detects distress or early signs of allergic reactions, providing crucial data that empowers parents and physicians to make informed decisions. The system predicts and identifies early signs of severe allergic reactions, enabling timely interventions that could potentially save a child's life.
Anjo.ai's business model revolves around a subscription-based service that includes remote monitoring through wearables. These wearables utilize AI and patent-pending technology to detect early signs of allergic reactions. The company also offers a daily risk factor analysis, identifying environmental, seasonal, or health-related triggers that may increase the likelihood of severe allergic reactions. This feature keeps parents informed about their child's wellness, including sleep and movement patterns, ensuring they remain within recommended guidelines.
Revenue is generated through subscriptions to its monitoring and alert services, as well as potential partnerships with healthcare providers and institutions. By providing a comprehensive view of physiological data, Anjo.ai not only helps parents but also enables physicians to make better care decisions.
In summary, Anjo.ai is a health tech startup that offers an AI-driven solution for managing severe allergies in children, serving parents and healthcare providers. It operates on a subscription-based model, providing remote monitoring, early detection, and risk factor analysis to empower informed decision-making.
Keywords: AI-driven, allergy management, children, health tech, wearables, early detection, data analysis, remote monitoring, subscription-based, personalized health.